Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Dietz, Allan B  [Clear All Filters]
2024
Bydon M, Qu W, Moinuddin FM, Hunt CL, Garlanger KL, Reeves RK, Windebank AJ, Zhao KD, Jarrah R, Trammell BC, et al. Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial. Nat Commun. 2024;15(1):2201.
2022
Dozois EJ, Lightner AL, Dietz AB, Fletcher JG, Lee YS, Friton JJ, Faubion WA. Durable Response Seen in Patients With Refractory Fistulizing Perianal Crohn's Disease Using Autologous Mesenchymal Stem Cells on a Dissolvable Matrix: Results from the Phase I Stem Cell on Matrix Plug (STOMP) Trial. Dis Colon Rectum. 2022.
2021
Lui H, Denbeigh J, Vaquette C, Tran HMy, Dietz AB, Cool SM, Dudakovic A, Kakar S, van Wijnen AJ. Fibroblastic Differentiation of Mesenchymal Stem/Stromal Cells (MSCs) is Enhanced by Hypoxia in 3D Cultures Treated with Bone Morphogenetic Protein 6 (BMP6) and Growth and Differentiation Factor 5 (GDF5). Gene. 2021:145662.
2020
Gluscevic M, Paradise CR, Dudakovic A, Karperien M, Dietz AB, van Wijnen AJ, Deyle DR. Functional Expression of ZNF467 and PCBP2 Supports Adipogenic Lineage Commitment in Adipose-derived Mesenchymal Stem Cells. Gene. 2020:144437.
Prasad M, Corban MT, Henry TD, Dietz AB, Lerman LO, Lerman A. Promise of Autologous CD34+ Stem/Progenitor Cell Therapy for Treatment of Cardiovascular Disease. Cardiovasc Res. 2020.
2019
Kubrova E, Qu W, M Galvan L, Paradise CR, Yang J, Dietz AB, Dudakovic A, Smith J, van Wijnen AJ. Hypothermia and nutrient deprivation alter viability of human adipose-derived mesenchymal stem cells. Gene. 2019:144058.
Lightner AL, Dozois EJ, Dietz AB, Fletcher JG, Friton J, Butler G, Faubion WA. Matrix-Delivered Autologous Mesenchymal Stem Cell Therapy for Refractory Rectovaginal Crohn's Fistulas. Inflamm Bowel Dis. 2019.
2016
Onishi K, Jones DL, Riester SM, Lewallen EA, Lewallen DG, Sellon JL, Dietz AB, Qu W, van Wijnen AJ, Smith J. Human Adipose-Derived Mesenchymal Stromal/Stem Cells Remain Viable and Metabolically Active Following Needle Passage. PM R. 2016.
Lewallen EA, Jones DL, Dudakovic A, Thaler R, Paradise CR, Kremers HM, Abdel MP, Kakar S, Dietz AB, Cohen RC, et al. Osteogenic potential of human adipose-tissue derived mesenchymal stromal cells cultured on 3D-printed porous structured titanium. Gene. 2016.
2015
Dave M, Mehta K, Luther J, Baruah A, Dietz AB, Faubion WA. Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2015.
Yang BX, Brahmbhatt A, Torres ENieves, Thielen B, McCall DL, Engel S, Bansal A, Pandey MK, Dietz AB, Leof EB, et al. Tracking and Therapeutic Value of Human Adipose Tissue-derived Mesenchymal Stem Cell Transplantation in Reducing Venous Neointimal Hyperplasia Associated with Arteriovenous Fistula. Radiology. 2015:150947.
2014
Dudakovic A, Camilleri E, Riester SM, Lewallen EA, Kvasha S, Chen X, Radel DJ, Anderson JM, Nair AA, Evans JM, et al. High-resolution molecular validation of self-renewal and spontaneous differentiation in adipose-tissue derived human mesenchymal stem cells cultured in human platelet lysate. J Cell Biochem. 2014.
Dudakovic A, Camilleri ET, Lewallen EA, McGee-Lawrence ME, Riester SM, Kakar S, Montecino M, Stein GS, Ryoo H-M, Dietz AB, et al. Histone deacetylase inhibition destabilizes the multi-potent state of uncommitted adipose-derived mesenchymal stromal cells. J Cell Physiol. 2014.